Pharmacological mechanisms of black cohosh in Sprague-Dawley rats

Fitoterapia. 2012 Apr;83(3):461-8. doi: 10.1016/j.fitote.2011.12.011. Epub 2011 Dec 16.

Abstract

Background: Studies indicate that extracts and purified components from black cohosh inhibit the growth of human breast cancer cells, but the molecular targets and signaling pathways have not yet been defined.

Purpose: This study examines the pharmacological mechanisms and toxicological effects in the short term of the herb black cohosh on female Sprague-Dawley rats.

Materials and methods: To assess effects on gene activity and lipid content, we treated female Sprague-Dawley rats with an extract of black cohosh enriched in triterpene glycosides (27%) at 35.7 or 0mg/kg. Four animals for each group were sacrificed at 1, 6 and 24h after treatment; liver tissue and serum samples were obtained for gene expression and lipid analysis.

Results: Microarray analysis of rat liver tissue indicated that black cohosh markedly downregulated mitochondrial oxidative phosphorylation genes. Phospholipid biosynthesis and remodeling, PI3-Kinase and sphingosine signaling were upregulated, driven largely by an upregulation of several isoforms of phospholipase C. Hierarchical clustering indicated that black cohosh clustered with antiproliferative compounds, specifically tubulin binding vinca alkaloids and DNA alkylators. In support of this, black cohosh repressed the expression of cyclin D1 and ID3, and inhibited the proliferation of HepG2, p53 positive, liver cancer cells. Black cohosh reduced the level of free fatty acids at 6 and 24h and triglycerides at 6h in the serum, but increased the free fatty acid and triglyceride content of the treated livers at 24h.

Conclusion: Our results suggest that black cohosh warrants further study for breast cancer prevention and therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Cell Proliferation / drug effects
  • Cimicifuga / chemistry*
  • Cyclin D / metabolism
  • Fatty Acids / metabolism
  • Female
  • Gene Expression / drug effects*
  • Glycosides / pharmacology
  • Glycosides / therapeutic use
  • Hep G2 Cells
  • Humans
  • Liver / drug effects*
  • Liver / metabolism
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / metabolism
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Oxidative Phosphorylation
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phytotherapy
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Sphingosine / metabolism
  • Triglycerides / metabolism
  • Triterpenes / pharmacology*
  • Triterpenes / therapeutic use
  • Tubulin / drug effects
  • Tumor Suppressor Protein p53 / metabolism
  • Type C Phospholipases / metabolism
  • Up-Regulation
  • Vinca / chemistry

Substances

  • Antineoplastic Agents, Phytogenic
  • Cyclin D
  • Fatty Acids
  • Glycosides
  • Plant Extracts
  • Triglycerides
  • Triterpenes
  • Tubulin
  • Tumor Suppressor Protein p53
  • Phosphatidylinositol 3-Kinases
  • Type C Phospholipases
  • Sphingosine